<!DOCTYPE html>
<html lang="en">

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta name="description" content="">
  <meta name="author" content="">

<title>PROGRAM - SIG: DRUG-DESIGN</title>

  <!-- Bootstrap core CSS -->
  <link href="vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">

  <!-- Custom fonts for this template -->
  <link href="https://fonts.googleapis.com/css?family=Raleway:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Lora:400,400i,700,700i" rel="stylesheet">

  <!-- Custom styles for this template -->
  <link href="css/business-casual.css" rel="stylesheet">

</head>

<body>

  <h1 class="site-heading text-center text-white d-none d-lg-block">
    <span class="site-heading-upper text-primary mb-3">Special Interest Group</span>
    <span class="site-heading-lower">DRUG-DESIGN</span>
  </h1>

  <!-- Navigation -->
  <nav class="navbar navbar-expand-lg navbar-dark py-lg-4" id="mainNav">
    <div class="container">
      <a class="navbar-brand text-uppercase text-expanded font-weight-bold d-lg-none" href="#">SIG: DRUG-DESIGN</a>
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>
      <div class="collapse navbar-collapse" id="navbarResponsive">
        <ul class="navbar-nav mx-auto">
          <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="index.html">Home
            </a>
          </li>
          <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="about.html">About
			      </a>
          </li>
        <li class="nav-item active px-lg-4">
          <a class="nav-link text-uppercase text-expanded" href="program.html">Program
          <span class="sr-only">(current)</span>
          </a>
        </li>
		      <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="conduct.html">Code of Conduct</a>
          </li>
          <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="registration.html">Registration</a>
          </li>
          <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="posters.html">Poster Session</a>
          </li>
		  <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="contact.html">Contact</a>
          </li>
        </ul>
      </div>
    </div>
  </nav>

  <section class="page-section cta">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-lg-4 order-lg-2">
					<div class="p-0 m-0" style="text-align:center">
            <h3 class="text-center text-white keynote">CONFIRMED SPEAKER</h3>
            <p></p>
            <a href="img/dparisi.png" target="_blank">
						<img class="img-fluid rounded-circle" src="img/parisi.jpg" alt="">
            </a>
            <p></p>
            <h5 class="text-center text-white">Daniele Parisi</h5>
            <h6 class="text-center text-white">Yale School of Medicine, USA</h6>
            <h6 class="text-center text-white">Postdoctoral Associate - Immunobiology</h6>
					</div>
				</div>
				<div class="col-lg-8 order-lg-1">
					<div class="bg-faded p-4 intro-text ml-auto rounded">
            <h5 class="text-center bold">Data fusion in drug-target interaction prediction for drug repositioning</h5>
            <p></p>
						<p class="mb-3" align="justify">    Identifying drug-target interactions is a crucial step in drug repositioning, the process of suggesting new indications for known drugs. There are about 9000 FDA-approved and experimental small molecule drugs and more than 500.000 protein records available. Performing in vitro experiments would be too expensive and time-consuming to check all the putative drug-target couples, therefore computational techniques might help to predict compound biological activity (IC50) and suggest new putative medical indications for existing drugs. Machine learning techniques such as Bayesian matrix factorization and deep neural networks can integrate structural information of drugs, proteins and their binding to better predict biological activity and suggest new drug-target interactions, with a big impact on the drug discovery process. Different kinds of side information can be used to help the prediction process, such as chemical structures of the drugs, 3D structures of the protein targets or phenotypic effect of drug-target interactions.
            In my work I analysed the contribution brought by different kinds of heterogeneous information in the prediction process, taking into account different modalities of validation, as well as advantages and difficulties related to the application of each specific type of data.
						</p>
					</div>
				</div>
			</div>
		</div>
	</section>

  <section class="page-section cta">
    <div class="container">
      <div class="row align-items-center">
        <div class="col-lg-4 order-lg-1">
          <div class="p-0 m-0" style="text-align:center">
            <h3 class="text-center text-white keynote">CONFIRMED SPEAKER</h3>
            <p></p>
            <a href="img/dovalle.png" target="_blank">
            <img class="img-fluid rounded-circle" src="img/italo.jpg" alt="">
            </a>
            <p></p>
            <h5 class="text-center text-white">Ítalo do Valle</h5>
            <h6 class="text-center text-white">Northeastern University, USA</h6>
            <h6 class="text-center text-white">Associate Research Scientist</h6>
          </div>
        </div>
        <div class="col-lg-8 order-lg-2">
          <div class="bg-faded p-4 intro-text ml-auto rounded">
            <h5 class="text-center bold">Network Medicine approaches for the study of complex diseases and discovery of new treatments</h5>
            <p></p>
            <p class="mb-3" align="justify"> A disease is rarely a consequence of an abnormality in a single gene or cell type but reflects the perturbations of the complex intracellular and intercellular networks that link tissues and organ systems. In the past decade, network medicine approaches have been developed to systematically explore the molecular complexity of a particular disease and its relationship with other phenotypes. The analysis of a comprehensive network of all known physical interactions between human proteins, transcription factors and metabolites, the human interactome, offers the possibility to uncover the biological significance of disease genes, reveal molecular mechanisms that connect different phenotypes, and help identify new pharmacological strategies for disease treatment. In this talk, we highlight the network medicine-based approaches developed in the past years and we show their applications for the understanding of diseases, and for the development of new therapeutic and prevention strategies.
            </p>
          </div>
        </div>
      </div>
    </div>
  </section>


  <footer class="footer text-faded text-center py-5">
    <div class="container">
      <div class="row justify-content-left">
        <div class="col-lg-1 col-md-12 col-xs-12" style="text-align: left;">
          <h3 class="my-4 text-footer-title" style="text-align: center">Organization</h3>
          <div style="text-align: center">
            <a href="http://rsg-brazil.iscbsc.org/" target="_blank">
              <img class="img-fluid" style="width: 120px" src="img/rsg.png" alt="">
            </a>
          </div>
        </div>
        <div class="col-lg-11 col-md-12 col-xs-12" style="text-align: left;">
          <h3 class="my-4 text-footer-title" style="text-align: center">Support</h3>
          <div  style="text-align: center">
            <div style="display: inline;">
              <a href="https://pgbcs.ioc.fiocruz.br/" target="_blank">
                <img class="img-fluid" style="height: 100px" src="img/bcs.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="http://www.fiocruz.br/ioc/cgi/cgilua.exe/sys/start.htm?tpl=home" target="_blank">
                <img class="img-fluid" style="height: 80px" src="img/ioc.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="https://portal.fiocruz.br/" target="_blank">
                <img class="img-fluid" style="height: 80px" src="img/fiocruz.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="https://www.iscbsc.org/" target="_blank">
                <img class="img-fluid" style="height: 70px" src="img/ISCBSC.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="https://www.ab3c.org.br/site/" target="_blank">
                <img class="img-fluid" style="height: 50px" src="img/AB3C.png" alt="">
              </a>
            </div>
          </div>
        </div>
      </div>
      <p class="m-0 text-footer-small" style="padding-top: 20px;">Copyright © SIG:DRUG-DESIGN 2020</p>
    </div>
  </footer>

  <!-- Bootstrap core JavaScript -->
  <script src="vendor/jquery/jquery.min.js"></script>
  <script src="vendor/bootstrap/js/bootstrap.bundle.min.js"></script>

</body>

</html>
